Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-08 · accession 0000950170-25-004052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-01-10 | 2025-01-08 | SANA | FMR LLC | 10%, See Remark 1 | S - Sale | $6.49 | -290.9K | 4.71M | -6% | -$1.89M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-08 | S | D | 100,000 | $6.11 | 4,732,423 | I F-Prime Capital Partners Life Sciences Fund VI LP | — | — | (F1) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.05 to $6.24. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-01-08 | S | D | 164,912 | $6.71 | 4,542,511 | I F-Prime Capital Partners Life Sciences Fund VI LP | — | — | (F3) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.20 to $6.98. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-01-08 | S | D | 1,000 | $7.26 | 4,541,511 | I F-Prime Capital Partners Life Sciences Fund VI LP | — | — | |
| 4 | Common | Common Stock | 2025-01-08 | S | D | 25,000 | $6.50 | 4,707,423 | I F-Prime Capital Partners Life Sciences Fund VI LP | — | — | (F2) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.50 to $6.55. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |